Analyst firms · BofA Securities · GMED

BofA Securities GMED price target and rating history

Globus Medical Inc. (GMED) · Health Care

BofA Securities rates Globus Medical Inc. (GMED) Buy with a $91 price target, as of its latest action on Nov 7, 2025. It has published 4 rating actions on GMED since December 2021, including 3 upgrades and 1 downgrade. Across 4 firms with a GMED price target in the last 12 months, the median target is $96.

Current rating
Buy
Price target
$91
Median target, all firms
$96
Actions on GMED
4

BofA Securities price target on GMED

$97$80$6320222023202420252026
BofA Securities price target on GMED, each point a stated target, December 2021 to November 2025.

Every BofA Securities rating on GMED

How other firms rate GMED

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BMO Capital MarketsMarket Perform$78Nov 6, 2026
UBSNeutral$82Jul 28, 2026
NeedhamBuy$112Jan 30, 2026
TD CowenBuy$110Jan 27, 2026

Questions about BofA Securities and GMED

What is BofA Securities's price target for GMED?
BofA Securities's latest stated price target for Globus Medical Inc. (GMED) is $91, from its action on Nov 7, 2025.
What is BofA Securities's rating on GMED?
BofA Securities rates GMED Buy, a bullish rating, as of Nov 7, 2025.
When did BofA Securities last change its view on GMED?
On Nov 7, 2025, BofA Securities upgrades to Buy from Neutral, price target $91.
How does BofA Securities's GMED target compare with other analysts?
Across 4 firms with a GMED price target in the last 12 months, the median target is $96.

More GMED rating histories

All BofA Securities ratingsGMED news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.